Torrent Pharma - Focus On Branded Generics, Profitability: HDFC Securities

Its two plants Dahej and Bileshwarpura (oral onco) received the U.S. FDA clearance, and it expects launch momentum to start from Q1 FY25
03-07-2024
Bigul

TORRENT PHARMACEUTICALS LTD. - 500420 - Announcement under Regulation 30 (LODR)-Newspaper Publication

Newspaper cuttings in connection with the 51st Annual General Meeting and E-Voting Procedure.
01-07-2024
Bigul

TORRENT PHARMACEUTICALS LTD. - 500420 - Submission Of The Annual Report For The FY 2023-24 And The Notice Convening 51St Annual General Meeting Of The Company.

Submission of the Annual Report for the FY 2023-24 and the Notice convening 51st AGM of the Company
29-06-2024
Bigul

TORRENT PHARMACEUTICALS LTD. - 500420 - Business Responsibility and Sustainability Reporting (BRSR)

Submission of the Business Responsibility and Sustainability Report (BRSR) for FY 2023-24 of the Company
29-06-2024
Bigul

TORRENT PHARMACEUTICALS LTD. - 500420 - Reg. 34 (1) Annual Report.

Submission of Annual Report for FY 2023-24 and intimation of voting through electronic means
29-06-2024
Bigul

TORRENT PHARMACEUTICALS LTD. - 500420 - Closure of Trading Window

Intimation of the Closure of Trading Window as per Company''s Code of Conduct to Regulate, Monitor and Report Trading by Designated Persons
28-06-2024
Bigul

TORRENT PHARMACEUTICALS LTD. - 500420 - Announcement under Regulation 30 (LODR)-Newspaper Publication

Newspaper Advertisement - Intimation of the 51st Annual General Meeting of the Company through Video Conferencing / Other Audio Visual Means ("VC / OAVM") facility
25-06-2024
Bigul

TORRENT PHARMACEUTICALS LTD. - 500420 - Disclosure Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015

Disclosure under regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
21-06-2024
Next Page
Close

Let's Open Free Demat Account